DK2717926T3

DK2717926T3 - COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM

COMPOSITIONS AND PROCEDURES FOR PREVENTION AND TREATMENT OF BIOFILM Download PDF

Info

Publication number: DK2717926T3
Authority: DK; Denmark
Prior art keywords: biofilm; trehalase; vol; trehalose; biofilms
Prior art date: 2011-06-13

Application number

DK12800279.7T

Other languages

Danish (da)

English (en)

Inventor

Dennis W Davis

Brad W Arenz

Thomas K Connellan

Svetlana A Ivanova

Original Assignee

Ziolase Llc

Priority date

2011-06-13

Filing date

2012-06-01

Publication date

2017-09-18

2012-06-01 Application filed by Ziolase Llc filed Critical Ziolase Llc

2017-09-18 Application granted granted Critical

2017-09-18 Publication of DK2717926T3 publication Critical patent/DK2717926T3/en

Links

238000011282 treatment Methods 0.000 title claims description 122
238000000034 method Methods 0.000 title claims description 108
239000000203 mixture Substances 0.000 title claims description 88
230000002265 prevention Effects 0.000 title claims description 12
108010087472 Trehalase Proteins 0.000 claims description 213
102100029677 Trehalase Human genes 0.000 claims description 168
102000004190 Enzymes Human genes 0.000 claims description 129
108090000790 Enzymes Proteins 0.000 claims description 129
229940088598 enzyme Drugs 0.000 claims description 129
208000015181 infectious disease Diseases 0.000 claims description 97
230000000813 microbial effect Effects 0.000 claims description 74
230000032770 biofilm formation Effects 0.000 claims description 44
230000012010 growth Effects 0.000 claims description 23
230000002458 infectious effect Effects 0.000 claims description 19
239000003139 biocide Substances 0.000 claims description 18
102000035195 Peptidases Human genes 0.000 claims description 17
108091005804 Peptidases Proteins 0.000 claims description 17
239000003527 fibrinolytic agent Substances 0.000 claims description 13
230000003480 fibrinolytic effect Effects 0.000 claims description 13
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 13
230000002366 lipolytic effect Effects 0.000 claims description 11
239000003599 detergent Substances 0.000 claims description 9
239000002738 chelating agent Substances 0.000 claims description 8
230000000593 degrading effect Effects 0.000 claims description 7
239000004094 surface-active agent Substances 0.000 claims description 7
238000010438 heat treatment Methods 0.000 claims description 3
239000003381 stabilizer Substances 0.000 claims description 3
238000004378 air conditioning Methods 0.000 claims description 2
238000009423 ventilation Methods 0.000 claims description 2
206010072064 Exposure to body fluid Diseases 0.000 claims 1
239000006172 buffering agent Substances 0.000 claims 1
239000007764 o/w emulsion Substances 0.000 claims 1
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 171
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 171
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 168
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 113
230000001580 bacterial effect Effects 0.000 description 110
241000894006 Bacteria Species 0.000 description 89
241000589517 Pseudomonas aeruginosa Species 0.000 description 65
230000000694 effects Effects 0.000 description 55
210000004027 cell Anatomy 0.000 description 49
230000015572 biosynthetic process Effects 0.000 description 48
244000005700 microbiome Species 0.000 description 48
239000004599 antimicrobial Substances 0.000 description 46
239000011159 matrix material Substances 0.000 description 43
230000003115 biocidal effect Effects 0.000 description 41
229920001282 polysaccharide Polymers 0.000 description 40
239000005017 polysaccharide Substances 0.000 description 40
108090000623 proteins and genes Proteins 0.000 description 39
239000000243 solution Substances 0.000 description 39
239000003242 anti bacterial agent Substances 0.000 description 37
229940088710 antibiotic agent Drugs 0.000 description 37
150000001875 compounds Chemical class 0.000 description 37
150000004676 glycans Chemical class 0.000 description 37
238000011109 contamination Methods 0.000 description 35
239000003795 chemical substances by application Substances 0.000 description 32
238000000576 coating method Methods 0.000 description 32
238000011161 development Methods 0.000 description 32
230000018109 developmental process Effects 0.000 description 32
241000282414 Homo sapiens Species 0.000 description 31
201000003883 Cystic fibrosis Diseases 0.000 description 30
230000007246 mechanism Effects 0.000 description 29
229920002444 Exopolysaccharide Polymers 0.000 description 28
230000001684 chronic effect Effects 0.000 description 28
239000000126 substance Substances 0.000 description 28
230000003993 interaction Effects 0.000 description 27
206010014665 endocarditis Diseases 0.000 description 25
238000013459 approach Methods 0.000 description 22
238000009472 formulation Methods 0.000 description 22
210000003709 heart valve Anatomy 0.000 description 22
238000004519 manufacturing process Methods 0.000 description 22
230000009885 systemic effect Effects 0.000 description 22
240000004808 Saccharomyces cerevisiae Species 0.000 description 21
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 21
239000000047 product Substances 0.000 description 21
230000003938 response to stress Effects 0.000 description 21
238000003786 synthesis reaction Methods 0.000 description 21
238000002604 ultrasonography Methods 0.000 description 21
241000588724 Escherichia coli Species 0.000 description 20
235000010443 alginic acid Nutrition 0.000 description 20
229920000615 alginic acid Polymers 0.000 description 20
230000000845 anti-microbial effect Effects 0.000 description 20
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 20
150000002016 disaccharides Chemical class 0.000 description 20
244000052769 pathogen Species 0.000 description 20
102000004169 proteins and genes Human genes 0.000 description 20
238000012552 review Methods 0.000 description 20
208000037581 Persistent Infection Diseases 0.000 description 19
238000009825 accumulation Methods 0.000 description 19
230000035508 accumulation Effects 0.000 description 19
229940072056 alginate Drugs 0.000 description 19
238000009792 diffusion process Methods 0.000 description 19
235000013305 food Nutrition 0.000 description 19
230000035515 penetration Effects 0.000 description 19
230000015556 catabolic process Effects 0.000 description 18
230000000968 intestinal effect Effects 0.000 description 18
235000018102 proteins Nutrition 0.000 description 18
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 17
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
230000037361 pathway Effects 0.000 description 17
-1 silver ions Chemical class 0.000 description 17
230000002485 urinary effect Effects 0.000 description 17
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 16
238000012512 characterization method Methods 0.000 description 16
238000006731 degradation reaction Methods 0.000 description 16
230000006870 function Effects 0.000 description 16
239000008103 glucose Substances 0.000 description 16
239000007943 implant Substances 0.000 description 16
230000004060 metabolic process Effects 0.000 description 16
230000018612 quorum sensing Effects 0.000 description 16
210000002345 respiratory system Anatomy 0.000 description 16
229910052709 silver Inorganic materials 0.000 description 16
239000004332 silver Substances 0.000 description 16
208000019206 urinary tract infection Diseases 0.000 description 16
208000027157 chronic rhinosinusitis Diseases 0.000 description 15
239000003921 oil Substances 0.000 description 15
210000001519 tissue Anatomy 0.000 description 15
230000032258 transport Effects 0.000 description 15
241000191967 Staphylococcus aureus Species 0.000 description 14
241000191963 Staphylococcus epidermidis Species 0.000 description 14
MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 14
150000002632 lipids Chemical class 0.000 description 14
229920000642 polymer Polymers 0.000 description 14
230000004083 survival effect Effects 0.000 description 14
230000008569 process Effects 0.000 description 13
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
241000588747 Klebsiella pneumoniae Species 0.000 description 12
241000589516 Pseudomonas Species 0.000 description 12
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
238000004140 cleaning Methods 0.000 description 12
238000000502 dialysis Methods 0.000 description 12
210000000959 ear middle Anatomy 0.000 description 12
230000002255 enzymatic effect Effects 0.000 description 12
230000007774 longterm Effects 0.000 description 12
239000012528 membrane Substances 0.000 description 12
230000008506 pathogenesis Effects 0.000 description 12
201000007094 prostatitis Diseases 0.000 description 12
238000004659 sterilization and disinfection Methods 0.000 description 12
230000035882 stress Effects 0.000 description 12
239000000758 substrate Substances 0.000 description 12
241000233866 Fungi Species 0.000 description 11
230000003111 delayed effect Effects 0.000 description 11
230000007613 environmental effect Effects 0.000 description 11
230000002068 genetic effect Effects 0.000 description 11
239000001257 hydrogen Substances 0.000 description 11
229910052739 hydrogen Inorganic materials 0.000 description 11
210000004379 membrane Anatomy 0.000 description 11
229920001296 polysiloxane Polymers 0.000 description 11
230000002797 proteolythic effect Effects 0.000 description 11
235000000346 sugar Nutrition 0.000 description 11
101710188648 Acid trehalase Proteins 0.000 description 10
241000222122 Candida albicans Species 0.000 description 10
230000006978 adaptation Effects 0.000 description 10
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
239000004744 fabric Substances 0.000 description 10
239000000499 gel Substances 0.000 description 10
210000003128 head Anatomy 0.000 description 10
201000007119 infective endocarditis Diseases 0.000 description 10
239000007788 liquid Substances 0.000 description 10
210000004072 lung Anatomy 0.000 description 10
235000015097 nutrients Nutrition 0.000 description 10
239000001301 oxygen Substances 0.000 description 10
229910052760 oxygen Inorganic materials 0.000 description 10
208000028169 periodontal disease Diseases 0.000 description 10
150000003904 phospholipids Chemical class 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
238000003860 storage Methods 0.000 description 10
241000196324 Embryophyta Species 0.000 description 9
206010033078 Otitis media Diseases 0.000 description 9
241000191940 Staphylococcus Species 0.000 description 9
208000009354 Trehalase deficiency Diseases 0.000 description 9
229910052799 carbon Inorganic materials 0.000 description 9
208000024035 chronic otitis media Diseases 0.000 description 9
230000007812 deficiency Effects 0.000 description 9
238000009826 distribution Methods 0.000 description 9
238000005516 engineering process Methods 0.000 description 9
210000001035 gastrointestinal tract Anatomy 0.000 description 9
230000014509 gene expression Effects 0.000 description 9
230000036571 hydration Effects 0.000 description 9
238000006703 hydration reaction Methods 0.000 description 9
239000000463 material Substances 0.000 description 9
238000005259 measurement Methods 0.000 description 9
230000002503 metabolic effect Effects 0.000 description 9
108010004131 poly(beta-D-mannuronate) lyase Proteins 0.000 description 9
239000002904 solvent Substances 0.000 description 9
210000001635 urinary tract Anatomy 0.000 description 9
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 8
241000222120 Candida <Saccharomycetales> Species 0.000 description 8
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
206010064687 Device related infection Diseases 0.000 description 8
241001646716 Escherichia coli K-12 Species 0.000 description 8
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 8
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
229930006000 Sucrose Natural products 0.000 description 8
230000009471 action Effects 0.000 description 8
239000007864 aqueous solution Substances 0.000 description 8
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 8
239000011248 coating agent Substances 0.000 description 8
239000000470 constituent Substances 0.000 description 8
238000001514 detection method Methods 0.000 description 8
229920000912 exopolymer Polymers 0.000 description 8
238000001727 in vivo Methods 0.000 description 8
230000002147 killing effect Effects 0.000 description 8
230000003239 periodontal effect Effects 0.000 description 8
238000011160 research Methods 0.000 description 8
238000004626 scanning electron microscopy Methods 0.000 description 8
210000000813 small intestine Anatomy 0.000 description 8
239000011780 sodium chloride Substances 0.000 description 8
239000005720 sucrose Substances 0.000 description 8
208000035143 Bacterial infection Diseases 0.000 description 7
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 7
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 7
241000606768 Haemophilus influenzae Species 0.000 description 7
108010044467 Isoenzymes Proteins 0.000 description 7
101000679327 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Cytosolic neutral trehalase Proteins 0.000 description 7
241000295644 Staphylococcaceae Species 0.000 description 7
108700016517 Trehalase Deficiency Proteins 0.000 description 7
210000004381 amniotic fluid Anatomy 0.000 description 7
208000022362 bacterial infectious disease Diseases 0.000 description 7
238000001574 biopsy Methods 0.000 description 7
229940095731 candida albicans Drugs 0.000 description 7
150000001720 carbohydrates Chemical class 0.000 description 7
229960003405 ciprofloxacin Drugs 0.000 description 7
230000007797 corrosion Effects 0.000 description 7
238000005260 corrosion Methods 0.000 description 7
230000007423 decrease Effects 0.000 description 7
239000000645 desinfectant Substances 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
210000002744 extracellular matrix Anatomy 0.000 description 7
239000012530 fluid Substances 0.000 description 7
206010023332 keratitis Diseases 0.000 description 7
229920002521 macromolecule Polymers 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
230000009467 reduction Effects 0.000 description 7
238000001356 surgical procedure Methods 0.000 description 7
241000228212 Aspergillus Species 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
208000034309 Bacterial disease carrier Diseases 0.000 description 6
108010001394 Disaccharidases Proteins 0.000 description 6
102000016359 Fibronectins Human genes 0.000 description 6
108010067306 Fibronectins Proteins 0.000 description 6
229910019142 PO4 Inorganic materials 0.000 description 6
KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 6
208000032536 Pseudomonas Infections Diseases 0.000 description 6
238000010521 absorption reaction Methods 0.000 description 6
238000004220 aggregation Methods 0.000 description 6
230000033228 biological regulation Effects 0.000 description 6
210000000170 cell membrane Anatomy 0.000 description 6
238000001816 cooling Methods 0.000 description 6
230000003247 decreasing effect Effects 0.000 description 6
238000010586 diagram Methods 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
229940047650 haemophilus influenzae Drugs 0.000 description 6
230000007062 hydrolysis Effects 0.000 description 6
238000006460 hydrolysis reaction Methods 0.000 description 6
230000005291 magnetic effect Effects 0.000 description 6
238000007726 management method Methods 0.000 description 6
230000001404 mediated effect Effects 0.000 description 6
239000002207 metabolite Substances 0.000 description 6
229910052751 metal Inorganic materials 0.000 description 6
239000002184 metal Substances 0.000 description 6
210000000214 mouth Anatomy 0.000 description 6
230000003204 osmotic effect Effects 0.000 description 6
230000008723 osmotic stress Effects 0.000 description 6
230000002085 persistent effect Effects 0.000 description 6
230000003449 preventive effect Effects 0.000 description 6
238000000746 purification Methods 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
230000004044 response Effects 0.000 description 6
238000007614 solvation Methods 0.000 description 6
150000008163 sugars Chemical class 0.000 description 6
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 5
108010053835 Catalase Proteins 0.000 description 5
102000016938 Catalase Human genes 0.000 description 5
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
208000002064 Dental Plaque Diseases 0.000 description 5
108010001682 Dextranase Proteins 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
229920000153 Povidone-iodine Polymers 0.000 description 5
206010040047 Sepsis Diseases 0.000 description 5
229920002472 Starch Polymers 0.000 description 5
241000194017 Streptococcus Species 0.000 description 5
239000007844 bleaching agent Substances 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
230000006652 catabolic pathway Effects 0.000 description 5
230000003197 catalytic effect Effects 0.000 description 5
238000005660 chlorination reaction Methods 0.000 description 5
239000000460 chlorine Substances 0.000 description 5
229910052801 chlorine Inorganic materials 0.000 description 5
239000000882 contact lens solution Substances 0.000 description 5
238000005202 decontamination Methods 0.000 description 5
230000003588 decontaminative effect Effects 0.000 description 5
102000038379 digestive enzymes Human genes 0.000 description 5
108091007734 digestive enzymes Proteins 0.000 description 5
230000029142 excretion Effects 0.000 description 5
238000011010 flushing procedure Methods 0.000 description 5
229930195712 glutamate Natural products 0.000 description 5
238000005470 impregnation Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
230000003902 lesion Effects 0.000 description 5
238000000329 molecular dynamics simulation Methods 0.000 description 5
210000004877 mucosa Anatomy 0.000 description 5
210000003097 mucus Anatomy 0.000 description 5
229960001621 povidone-iodine Drugs 0.000 description 5
239000006041 probiotic Substances 0.000 description 5
235000018291 probiotics Nutrition 0.000 description 5
208000011354 prosthesis-related infectious disease Diseases 0.000 description 5
230000011664 signaling Effects 0.000 description 5
229910001220 stainless steel Inorganic materials 0.000 description 5
239000010935 stainless steel Substances 0.000 description 5
239000008107 starch Substances 0.000 description 5
235000019698 starch Nutrition 0.000 description 5
230000002123 temporal effect Effects 0.000 description 5
210000002700 urine Anatomy 0.000 description 5
230000002792 vascular Effects 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
241001225321 Aspergillus fumigatus Species 0.000 description 4
206010009137 Chronic sinusitis Diseases 0.000 description 4
241000557626 Corvus corax Species 0.000 description 4
208000005156 Dehydration Diseases 0.000 description 4
229920002307 Dextran Polymers 0.000 description 4
241000194032 Enterococcus faecalis Species 0.000 description 4
241000282412 Homo Species 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
240000006240 Linum usitatissimum Species 0.000 description 4
235000004431 Linum usitatissimum Nutrition 0.000 description 4
241000187479 Mycobacterium tuberculosis Species 0.000 description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
241000588770 Proteus mirabilis Species 0.000 description 4
241000194019 Streptococcus mutans Species 0.000 description 4
230000004913 activation Effects 0.000 description 4
230000002776 aggregation Effects 0.000 description 4
230000032683 aging Effects 0.000 description 4
230000004075 alteration Effects 0.000 description 4
229940126575 aminoglycoside Drugs 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000037358 bacterial metabolism Effects 0.000 description 4
244000052616 bacterial pathogen Species 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
235000013405 beer Nutrition 0.000 description 4
230000008901 benefit Effects 0.000 description 4
229960003237 betaine Drugs 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000007795 chemical reaction product Substances 0.000 description 4
230000006378 damage Effects 0.000 description 4
230000007123 defense Effects 0.000 description 4
238000006073 displacement reaction Methods 0.000 description 4
239000002158 endotoxin Substances 0.000 description 4
210000002919 epithelial cell Anatomy 0.000 description 4
210000003754 fetus Anatomy 0.000 description 4
239000007789 gas Substances 0.000 description 4
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
239000003292 glue Substances 0.000 description 4
KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
210000000224 granular leucocyte Anatomy 0.000 description 4
238000001631 haemodialysis Methods 0.000 description 4
230000000322 hemodialysis Effects 0.000 description 4
238000002513 implantation Methods 0.000 description 4
238000011065 in-situ storage Methods 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
229910052500 inorganic mineral Inorganic materials 0.000 description 4
239000002609 medium Substances 0.000 description 4
235000013336 milk Nutrition 0.000 description 4
239000008267 milk Substances 0.000 description 4
210000004080 milk Anatomy 0.000 description 4
239000011707 mineral Substances 0.000 description 4
108020004707 nucleic acids Proteins 0.000 description 4
102000039446 nucleic acids Human genes 0.000 description 4
150000007523 nucleic acids Chemical class 0.000 description 4
229920001542 oligosaccharide Polymers 0.000 description 4
230000000399 orthopedic effect Effects 0.000 description 4
230000000065 osmolyte Effects 0.000 description 4
201000001245 periodontitis Diseases 0.000 description 4
239000003208 petroleum Substances 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
235000021317 phosphate Nutrition 0.000 description 4
230000035479 physiological effects, processes and functions Effects 0.000 description 4
238000009428 plumbing Methods 0.000 description 4
229920000728 polyester Polymers 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000000529 probiotic effect Effects 0.000 description 4
238000012545 processing Methods 0.000 description 4
230000002685 pulmonary effect Effects 0.000 description 4
150000003856 quaternary ammonium compounds Chemical class 0.000 description 4
230000000306 recurrent effect Effects 0.000 description 4
210000003296 saliva Anatomy 0.000 description 4
238000009958 sewing Methods 0.000 description 4
238000004088 simulation Methods 0.000 description 4
241000894007 species Species 0.000 description 4
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 4
229960000707 tobramycin Drugs 0.000 description 4
206010044008 tonsillitis Diseases 0.000 description 4
239000000606 toothpaste Substances 0.000 description 4
230000001018 virulence Effects 0.000 description 4
230000007279 water homeostasis Effects 0.000 description 4
108010074725 Alpha,alpha-trehalose phosphorylase Proteins 0.000 description 3
239000004382 Amylase Substances 0.000 description 3
108010065511 Amylases Proteins 0.000 description 3
102000013142 Amylases Human genes 0.000 description 3
201000004538 Bacteriuria Diseases 0.000 description 3
206010007134 Candida infections Diseases 0.000 description 3
229920002101 Chitin Polymers 0.000 description 3
206010009152 Chronic tonsillitis Diseases 0.000 description 3
241000238586 Cirripedia Species 0.000 description 3
108010065152 Coagulase Proteins 0.000 description 3
101710145116 Cytoplasmic trehalase Proteins 0.000 description 3
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
108090000204 Dipeptidase 1 Proteins 0.000 description 3
241000588722 Escherichia Species 0.000 description 3
241000628997 Flos Species 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
229920002306 Glycocalyx Polymers 0.000 description 3
229920002527 Glycogen Polymers 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
101000633605 Homo sapiens Thrombospondin-2 Proteins 0.000 description 3
108090000862 Ion Channels Proteins 0.000 description 3
102000004310 Ion Channels Human genes 0.000 description 3
241000589248 Legionella Species 0.000 description 3
241000589242 Legionella pneumophila Species 0.000 description 3
208000007764 Legionnaires' Disease Diseases 0.000 description 3
241001514698 Leucosporidium creatinivorum Species 0.000 description 3
241000186779 Listeria monocytogenes Species 0.000 description 3
229920002774 Maltodextrin Polymers 0.000 description 3
239000005913 Maltodextrin Substances 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
241000588772 Morganella morganii Species 0.000 description 3
241000187480 Mycobacterium smegmatis Species 0.000 description 3
206010034133 Pathogen resistance Diseases 0.000 description 3
101710126953 Periplasmic trehalase Proteins 0.000 description 3
241000605862 Porphyromonas gingivalis Species 0.000 description 3
108010026552 Proteome Proteins 0.000 description 3
241000588769 Proteus <enterobacteria> Species 0.000 description 3
238000001069 Raman spectroscopy Methods 0.000 description 3
241000235070 Saccharomyces Species 0.000 description 3
241000607720 Serratia Species 0.000 description 3
241000607715 Serratia marcescens Species 0.000 description 3
241000123447 Solicoccozyma terreus Species 0.000 description 3
241000607626 Vibrio cholerae Species 0.000 description 3
206010052428 Wound Diseases 0.000 description 3
210000002534 adenoid Anatomy 0.000 description 3
101150059055 algC gene Proteins 0.000 description 3
229960000723 ampicillin Drugs 0.000 description 3
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
235000019418 amylase Nutrition 0.000 description 3
230000003214 anti-biofilm Effects 0.000 description 3
229940091771 aspergillus fumigatus Drugs 0.000 description 3
230000003190 augmentative effect Effects 0.000 description 3
230000010065 bacterial adhesion Effects 0.000 description 3
102000006635 beta-lactamase Human genes 0.000 description 3
238000010364 biochemical engineering Methods 0.000 description 3
239000006227 byproduct Substances 0.000 description 3
239000011575 calcium Substances 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
201000003984 candidiasis Diseases 0.000 description 3
239000002775 capsule Substances 0.000 description 3
239000003638 chemical reducing agent Substances 0.000 description 3
238000010367 cloning Methods 0.000 description 3
238000004624 confocal microscopy Methods 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
210000000172 cytosol Anatomy 0.000 description 3
208000002925 dental caries Diseases 0.000 description 3
230000003292 diminished effect Effects 0.000 description 3
239000002270 dispersing agent Substances 0.000 description 3
210000003038 endothelium Anatomy 0.000 description 3
238000001952 enzyme assay Methods 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
230000002349 favourable effect Effects 0.000 description 3
235000013373 food additive Nutrition 0.000 description 3
239000002778 food additive Substances 0.000 description 3
150000002241 furanones Chemical class 0.000 description 3
239000011521 glass Substances 0.000 description 3
210000004517 glycocalyx Anatomy 0.000 description 3
229940096919 glycogen Drugs 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000036541 health Effects 0.000 description 3
210000002216 heart Anatomy 0.000 description 3
239000000017 hydrogel Substances 0.000 description 3
238000007654 immersion Methods 0.000 description 3
230000028993 immune response Effects 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
238000011835 investigation Methods 0.000 description 3
230000002262 irrigation Effects 0.000 description 3
238000003973 irrigation Methods 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
229940115932 legionella pneumophila Drugs 0.000 description 3
239000000314 lubricant Substances 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
210000002540 macrophage Anatomy 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
229940035034 maltodextrin Drugs 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
230000035800 maturation Effects 0.000 description 3
210000000110 microvilli Anatomy 0.000 description 3
229940076266 morganella morganii Drugs 0.000 description 3
239000002324 mouth wash Substances 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
150000002482 oligosaccharides Chemical class 0.000 description 3
230000002688 persistence Effects 0.000 description 3
229920005862 polyol Polymers 0.000 description 3
230000002980 postoperative effect Effects 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
230000002335 preservative effect Effects 0.000 description 3
235000019833 protease Nutrition 0.000 description 3
FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 description 3
101150076849 rpoS gene Proteins 0.000 description 3
230000028327 secretion Effects 0.000 description 3
229920000260 silastic Polymers 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
230000036962 time dependent Effects 0.000 description 3
229940034610 toothpaste Drugs 0.000 description 3
108010020589 trehalose-6-phosphate synthase Proteins 0.000 description 3
108020003272 trehalose-phosphatase Proteins 0.000 description 3
150000003625 trehaloses Chemical class 0.000 description 3
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 2
AYRXSINWFIIFAE-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal Chemical compound OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 2
101150111419 ATH1 gene Proteins 0.000 description 2
HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
241000186361 Actinobacteria <class> Species 0.000 description 2
235000001674 Agaricus brunnescens Nutrition 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
101100433747 Arabidopsis thaliana ABCA2 gene Proteins 0.000 description 2
101100288148 Arabidopsis thaliana KNAT5 gene Proteins 0.000 description 2
101100135611 Arabidopsis thaliana PAP12 gene Proteins 0.000 description 2
101150002428 Atoh1 gene Proteins 0.000 description 2
241000193830 Bacillus <bacterium> Species 0.000 description 2
244000063299 Bacillus subtilis Species 0.000 description 2
235000014469 Bacillus subtilis Nutrition 0.000 description 2
101000634892 Bacillus subtilis (strain 168) Trehalose-6-phosphate hydrolase Proteins 0.000 description 2
102100026189 Beta-galactosidase Human genes 0.000 description 2
108090001003 Beta-phosphoglucomutases Proteins 0.000 description 2
239000002028 Biomass Substances 0.000 description 2
241001474374 Blennius Species 0.000 description 2
206010006458 Bronchitis chronic Diseases 0.000 description 2
241000589513 Burkholderia cepacia Species 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
101100057132 Candida albicans (strain SC5314 / ATCC MYA-2876) ATC1 gene Proteins 0.000 description 2
108091006146 Channels Proteins 0.000 description 2
241000700112 Chinchilla Species 0.000 description 2
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
208000035473 Communicable disease Diseases 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
241000186216 Corynebacterium Species 0.000 description 2
241000186226 Corynebacterium glutamicum Species 0.000 description 2
241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 2
206010011409 Cross infection Diseases 0.000 description 2
102000012605 Cystic Fibrosis Transmembrane Conductance Regulator Human genes 0.000 description 2
108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 2
206010011763 Cystic fibrosis lung Diseases 0.000 description 2
GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
235000005903 Dioscorea Nutrition 0.000 description 2
244000281702 Dioscorea villosa Species 0.000 description 2
235000000504 Dioscorea villosa Nutrition 0.000 description 2
208000032163 Emerging Communicable disease Diseases 0.000 description 2
206010014666 Endocarditis bacterial Diseases 0.000 description 2
241001267419 Eubacterium sp. Species 0.000 description 2
238000005079 FT-Raman Methods 0.000 description 2
102000009123 Fibrin Human genes 0.000 description 2
108010073385 Fibrin Proteins 0.000 description 2
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
102000008946 Fibrinogen Human genes 0.000 description 2
108010049003 Fibrinogen Proteins 0.000 description 2
206010017533 Fungal infection Diseases 0.000 description 2
241000605986 Fusobacterium nucleatum Species 0.000 description 2
208000018522 Gastrointestinal disease Diseases 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
241000771318 Haemophilus influenzae 86-028NP Species 0.000 description 2
208000028782 Hereditary disease Diseases 0.000 description 2
102100037850 Interferon gamma Human genes 0.000 description 2
108010074328 Interferon-gamma Proteins 0.000 description 2
241000186660 Lactobacillus Species 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
102000007547 Laminin Human genes 0.000 description 2
108010085895 Laminin Proteins 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
108090001060 Lipase Proteins 0.000 description 2
102000004882 Lipase Human genes 0.000 description 2
239000004367 Lipase Substances 0.000 description 2
208000032376 Lung infection Diseases 0.000 description 2
208000024556 Mendelian disease Diseases 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000736262 Microbiota Species 0.000 description 2
241000588655 Moraxella catarrhalis Species 0.000 description 2
108010014251 Muramidase Proteins 0.000 description 2
102000016943 Muramidase Human genes 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
241000244206 Nematoda Species 0.000 description 2
208000005141 Otitis Diseases 0.000 description 2
206010033101 Otorrhoea Diseases 0.000 description 2
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
208000005888 Periodontal Pocket Diseases 0.000 description 2
102000003992 Peroxidases Human genes 0.000 description 2
206010035664 Pneumonia Diseases 0.000 description 2
241001135221 Prevotella intermedia Species 0.000 description 2
206010036790 Productive cough Diseases 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
241000223252 Rhodotorula Species 0.000 description 2
101150014136 SUC2 gene Proteins 0.000 description 2
206010073742 Streptococcal endocarditis Diseases 0.000 description 2
241000193998 Streptococcus pneumoniae Species 0.000 description 2
241000194023 Streptococcus sanguinis Species 0.000 description 2
241001312524 Streptococcus viridans Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
241000205180 Thermococcus litoralis Species 0.000 description 2
241000204652 Thermotoga Species 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
102100029529 Thrombospondin-2 Human genes 0.000 description 2
102100029373 Transcription factor ATOH1 Human genes 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
108010046334 Urease Proteins 0.000 description 2
108010059993 Vancomycin Proteins 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
206010051223 adenoiditis Diseases 0.000 description 2
230000001464 adherent effect Effects 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
230000009603 aerobic growth Effects 0.000 description 2
102000004139 alpha-Amylases Human genes 0.000 description 2
108090000637 alpha-Amylases Proteins 0.000 description 2
WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 2
108010028144 alpha-Glucosidases Proteins 0.000 description 2
229940024171 alpha-amylase Drugs 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
230000009604 anaerobic growth Effects 0.000 description 2
230000003373 anti-fouling effect Effects 0.000 description 2
238000011203 antimicrobial therapy Methods 0.000 description 2
241000617156 archaeon Species 0.000 description 2
208000009361 bacterial endocarditis Diseases 0.000 description 2
235000015173 baked goods and baking mixes Nutrition 0.000 description 2
HXXFSFRBOHSIMQ-DVKNGEFBSA-N beta-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-DVKNGEFBSA-N 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
239000011942 biocatalyst Substances 0.000 description 2
230000003592 biomimetic effect Effects 0.000 description 2
229920001222 biopolymer Polymers 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
206010006451 bronchitis Diseases 0.000 description 2
FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
108010089934 carbohydrase Proteins 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
230000030833 cell death Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
229940112822 chewing gum Drugs 0.000 description 2
235000015218 chewing gum Nutrition 0.000 description 2
229960003260 chlorhexidine Drugs 0.000 description 2
YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
229960003333 chlorhexidine gluconate Drugs 0.000 description 2
208000007451 chronic bronchitis Diseases 0.000 description 2
231100000749 chronicity Toxicity 0.000 description 2
210000004081 cilia Anatomy 0.000 description 2
230000000112 colonic effect Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000002591 computed tomography Methods 0.000 description 2
238000009833 condensation Methods 0.000 description 2
230000005494 condensation Effects 0.000 description 2
230000003750 conditioning effect Effects 0.000 description 2
230000010485 coping Effects 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
239000010949 copper Substances 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
230000018044 dehydration Effects 0.000 description 2
238000006297 dehydration reaction Methods 0.000 description 2
230000001934 delay Effects 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000001066 destructive effect Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000000378 dietary effect Effects 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
208000010643 digestive system disease Diseases 0.000 description 2
235000004879 dioscorea Nutrition 0.000 description 2
OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
239000001177 diphosphate Substances 0.000 description 2
235000011180 diphosphates Nutrition 0.000 description 2
WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
210000001198 duodenum Anatomy 0.000 description 2
208000019258 ear infection Diseases 0.000 description 2
230000005684 electric field Effects 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
230000008029 eradication Effects 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
238000000605 extraction Methods 0.000 description 2
210000001508 eye Anatomy 0.000 description 2
229950003499 fibrin Drugs 0.000 description 2
229940012952 fibrinogen Drugs 0.000 description 2
238000001914 filtration Methods 0.000 description 2
230000037406 food intake Effects 0.000 description 2
239000000446 fuel Substances 0.000 description 2
208000018685 gastrointestinal system disease Diseases 0.000 description 2
238000001879 gelation Methods 0.000 description 2
210000004195 gingiva Anatomy 0.000 description 2
230000034659 glycolysis Effects 0.000 description 2
244000005709 gut microbiome Species 0.000 description 2
230000002949 hemolytic effect Effects 0.000 description 2
108010037896 heparin-binding hemagglutinin Proteins 0.000 description 2
235000012907 honey Nutrition 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000003301 hydrolyzing effect Effects 0.000 description 2
235000015243 ice cream Nutrition 0.000 description 2
230000036039 immunity Effects 0.000 description 2
239000000411 inducer Substances 0.000 description 2
239000008235 industrial water Substances 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
230000009878 intermolecular interaction Effects 0.000 description 2
230000003870 intestinal permeability Effects 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000002372 labelling Methods 0.000 description 2
229940116108 lactase Drugs 0.000 description 2
229940039696 lactobacillus Drugs 0.000 description 2
239000008101 lactose Substances 0.000 description 2
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 2
229960000511 lactulose Drugs 0.000 description 2
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 2
239000004816 latex Substances 0.000 description 2
229920000126 latex Polymers 0.000 description 2
235000019421 lipase Nutrition 0.000 description 2
239000002502 liposome Substances 0.000 description 2
239000006194 liquid suspension Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
230000004807 localization Effects 0.000 description 2
229960000274 lysozyme Drugs 0.000 description 2
239000004325 lysozyme Substances 0.000 description 2
108010074674 maltooligosyl trehalose trehalohydrolase Proteins 0.000 description 2
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
244000000010 microbial pathogen Species 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
230000000116 mitigating effect Effects 0.000 description 2
238000013113 molecular simulation experiment Methods 0.000 description 2
235000013919 monopotassium glutamate Nutrition 0.000 description 2
230000001338 necrotic effect Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
229910052759 nickel Inorganic materials 0.000 description 2
239000002777 nucleoside Substances 0.000 description 2
239000002674 ointment Substances 0.000 description 2
210000003300 oropharynx Anatomy 0.000 description 2
230000010355 oscillation Effects 0.000 description 2
230000001590 oxidative effect Effects 0.000 description 2
210000002741 palatine tonsil Anatomy 0.000 description 2
244000045947 parasite Species 0.000 description 2
239000002245 particle Substances 0.000 description 2
230000003950 pathogenic mechanism Effects 0.000 description 2
230000007918 pathogenicity Effects 0.000 description 2
238000000059 patterning Methods 0.000 description 2
150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
229960002292 piperacillin Drugs 0.000 description 2
WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000003793 prenatal diagnosis Methods 0.000 description 2
235000013324 preserved food Nutrition 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
238000005057 refrigeration Methods 0.000 description 2
238000005067 remediation Methods 0.000 description 2
210000001533 respiratory mucosa Anatomy 0.000 description 2
230000028160 response to osmotic stress Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000001350 scanning transmission electron microscopy Methods 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
238000007493 shaping process Methods 0.000 description 2
NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
210000003802 sputum Anatomy 0.000 description 2
208000024794 sputum Diseases 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
229940031000 streptococcus pneumoniae Drugs 0.000 description 2
229910052567 struvite Inorganic materials 0.000 description 2
239000013589 supplement Substances 0.000 description 2
230000008093 supporting effect Effects 0.000 description 2
238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000002195 synergetic effect Effects 0.000 description 2
239000003826 tablet Substances 0.000 description 2
230000008719 thickening Effects 0.000 description 2
MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
230000000451 tissue damage Effects 0.000 description 2
231100000827 tissue damage Toxicity 0.000 description 2
QQJLHRRUATVHED-UHFFFAOYSA-N tramazoline Chemical compound N1CCN=C1NC1=CC=CC2=C1CCCC2 QQJLHRRUATVHED-UHFFFAOYSA-N 0.000 description 2
229960001262 tramazoline Drugs 0.000 description 2
238000012546 transfer Methods 0.000 description 2
LABSPYBHMPDTEL-JGZVXCDNSA-N trehalose-6-phosphate Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](COP(O)(O)=O)O1 LABSPYBHMPDTEL-JGZVXCDNSA-N 0.000 description 2
PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 2
210000003708 urethra Anatomy 0.000 description 2
210000003934 vacuole Anatomy 0.000 description 2
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
229960003165 vancomycin Drugs 0.000 description 2
238000012795 verification Methods 0.000 description 2
239000002699 waste material Substances 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical class CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 1
MCNQUWLLXZZZAC-UHFFFAOYSA-N 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-n-piperidin-1-ylpyrazole-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C#N)C(C(=O)NN2CCCCC2)=NN1C1=CC=C(Cl)C=C1Cl MCNQUWLLXZZZAC-UHFFFAOYSA-N 0.000 description 1
108010011619 6-Phytase Proteins 0.000 description 1
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 1
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
241000224422 Acanthamoeba Species 0.000 description 1
241000590020 Achromobacter Species 0.000 description 1
241000589291 Acinetobacter Species 0.000 description 1
241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
241000186045 Actinomyces naeslundii Species 0.000 description 1
241000321096 Adenoides Species 0.000 description 1
101710186708 Agglutinin Proteins 0.000 description 1
101710105077 Agglutinin-1 Proteins 0.000 description 1
241000606828 Aggregatibacter aphrophilus Species 0.000 description 1
108090000915 Aminopeptidases Proteins 0.000 description 1
102000004400 Aminopeptidases Human genes 0.000 description 1
229920000856 Amylose Polymers 0.000 description 1
206010002660 Anoxia Diseases 0.000 description 1
241000976983 Anoxia Species 0.000 description 1
241000219194 Arabidopsis Species 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
241001148536 Bacteroides sp. Species 0.000 description 1
CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 description 1
235000018185 Betula X alpestris Nutrition 0.000 description 1
235000018212 Betula X uliginosa Nutrition 0.000 description 1
XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
229940123208 Biguanide Drugs 0.000 description 1
241001453380 Burkholderia Species 0.000 description 1
CGPHZDRCVSLMCF-JZMIEXBBSA-N CDP-alpha-D-glucose Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 CGPHZDRCVSLMCF-JZMIEXBBSA-N 0.000 description 1
241000589996 Campylobacter rectus Species 0.000 description 1
241000282461 Canis lupus Species 0.000 description 1
108010006303 Carboxypeptidases Proteins 0.000 description 1
102000005367 Carboxypeptidases Human genes 0.000 description 1
108010031396 Catechol oxidase Proteins 0.000 description 1
102000030523 Catechol oxidase Human genes 0.000 description 1
208000032840 Catheter-Related Infections Diseases 0.000 description 1
108010059892 Cellulase Proteins 0.000 description 1
241000700114 Chinchillidae Species 0.000 description 1
108010022172 Chitinases Proteins 0.000 description 1
102000012286 Chitinases Human genes 0.000 description 1
102000011045 Chloride Channels Human genes 0.000 description 1
108010062745 Chloride Channels Proteins 0.000 description 1
239000004155 Chlorine dioxide Substances 0.000 description 1
206010008642 Cholesteatoma Diseases 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
241000222290 Cladosporium Species 0.000 description 1
208000015943 Coeliac disease Diseases 0.000 description 1
108010078777 Colistin Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
201000007336 Cryptococcosis Diseases 0.000 description 1
241001337994 Cryptococcus <scale insect> Species 0.000 description 1
241000221204 Cryptococcus neoformans Species 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
229920002558 Curdlan Polymers 0.000 description 1
239000001879 Curdlan Substances 0.000 description 1
108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
102000005927 Cysteine Proteases Human genes 0.000 description 1
108010005843 Cysteine Proteases Proteins 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
241000122827 Delisea pulchra Species 0.000 description 1
208000006558 Dental Calculus Diseases 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
241001535058 Dialister pneumosintes Species 0.000 description 1
WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 1
101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
206010062608 Endocarditis noninfective Diseases 0.000 description 1
102100021710 Endonuclease III-like protein 1 Human genes 0.000 description 1
241000305071 Enterobacterales Species 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
108010017707 Fibronectin Receptors Proteins 0.000 description 1
241001065700 Ficus glabrata Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
241000589565 Flavobacterium Species 0.000 description 1
241000605909 Fusobacterium Species 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
MVMSCBBUIHUTGJ-LRJDVEEWSA-N GDP-alpha-D-glucose Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=C(NC(=O)C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O MVMSCBBUIHUTGJ-LRJDVEEWSA-N 0.000 description 1
241000207202 Gardnerella Species 0.000 description 1
229920002148 Gellan gum Polymers 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
208000034619 Gingival inflammation Diseases 0.000 description 1
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
229920001503 Glucan Polymers 0.000 description 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
102100022624 Glucoamylase Human genes 0.000 description 1
108010055629 Glucosyltransferases Proteins 0.000 description 1
102000000340 Glucosyltransferases Human genes 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
229930186217 Glycolipid Natural products 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
206010019909 Hernia Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101000970385 Homo sapiens Endonuclease III-like protein 1 Proteins 0.000 description 1
101000981685 Homo sapiens Protein Lines homolog 1 Proteins 0.000 description 1
101000795130 Homo sapiens Trehalase Proteins 0.000 description 1
101710146024 Horcolin Proteins 0.000 description 1
206010020880 Hypertrophy Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
108010093096 Immobilized Enzymes Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010028688 Isoamylase Proteins 0.000 description 1
AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
241000588748 Klebsiella Species 0.000 description 1
241000588915 Klebsiella aerogenes Species 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
108010029541 Laccase Proteins 0.000 description 1
108010059881 Lactase Proteins 0.000 description 1
241000194036 Lactococcus Species 0.000 description 1
101710189395 Lectin Proteins 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 description 1
208000024369 Libman-Sacks endocarditis Diseases 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
108090000856 Lyases Proteins 0.000 description 1
102000004317 Lyases Human genes 0.000 description 1
206010025476 Malabsorption Diseases 0.000 description 1
208000004155 Malabsorption Syndromes Diseases 0.000 description 1
101710179758 Mannose-specific lectin Proteins 0.000 description 1
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
108010054377 Mannosidases Proteins 0.000 description 1
102000001696 Mannosidases Human genes 0.000 description 1
241000589323 Methylobacterium Species 0.000 description 1
241000192041 Micrococcus Species 0.000 description 1
241000219470 Mirabilis Species 0.000 description 1
241001494429 Mogibacterium timidum Species 0.000 description 1
241000588621 Moraxella Species 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
PHSRRHGYXQCRPU-AWEZNQCLSA-N N-(3-oxododecanoyl)-L-homoserine lactone Chemical group CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O PHSRRHGYXQCRPU-AWEZNQCLSA-N 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010031252 Osteomyelitis Diseases 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
241001464887 Parvimonas micra Species 0.000 description 1
241001639979 Peixotoa Species 0.000 description 1
241000228143 Penicillium Species 0.000 description 1
108700020962 Peroxidase Proteins 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
201000007100 Pharyngitis Diseases 0.000 description 1
102000030605 Phosphomannomutase Human genes 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108010089430 Phosphoproteins Proteins 0.000 description 1
102000007982 Phosphoproteins Human genes 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
108010013381 Porins Proteins 0.000 description 1
102000017033 Porins Human genes 0.000 description 1
241000605894 Porphyromonas Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100024087 Protein Lines homolog 1 Human genes 0.000 description 1
229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
241000588767 Proteus vulgaris Species 0.000 description 1
241000588778 Providencia stuartii Species 0.000 description 1
101100361766 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) algU gene Proteins 0.000 description 1
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
208000035977 Rare disease Diseases 0.000 description 1
208000037340 Rare genetic disease Diseases 0.000 description 1
235000001537 Ribes X gardonianum Nutrition 0.000 description 1
235000001535 Ribes X utile Nutrition 0.000 description 1
235000016919 Ribes petraeum Nutrition 0.000 description 1
244000281247 Ribes rubrum Species 0.000 description 1
235000002355 Ribes spicatum Nutrition 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010017507 Ricinus communis agglutinin-1 Proteins 0.000 description 1
241000985259 Selenomonas sputigena Species 0.000 description 1
ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
241000589970 Spirochaetales Species 0.000 description 1
208000014151 Stomatognathic disease Diseases 0.000 description 1
241000194049 Streptococcus equinus Species 0.000 description 1
244000057717 Streptococcus lactis Species 0.000 description 1
235000014897 Streptococcus lactis Nutrition 0.000 description 1
241000193996 Streptococcus pyogenes Species 0.000 description 1
108010040715 Sucrase-Isomaltase Complex Proteins 0.000 description 1
102100027918 Sucrase-isomaltase, intestinal Human genes 0.000 description 1
241000205101 Sulfolobus Species 0.000 description 1
241000205098 Sulfolobus acidocaldarius Species 0.000 description 1
241000973887 Takayama Species 0.000 description 1
241001523006 Talaromyces marneffei Species 0.000 description 1
241001135235 Tannerella forsythia Species 0.000 description 1
206010057040 Temperature intolerance Diseases 0.000 description 1
239000005844 Thymol Substances 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
241000592342 Tracheophyta Species 0.000 description 1
108060008539 Transglutaminase Proteins 0.000 description 1
206010066901 Treatment failure Diseases 0.000 description 1
108010011224 Trehalose 6-phosphate phosphorylase Proteins 0.000 description 1
HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 1
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
240000003864 Ulex europaeus Species 0.000 description 1
235000010730 Ulex europaeus Nutrition 0.000 description 1
208000024248 Vascular System injury Diseases 0.000 description 1
208000012339 Vascular injury Diseases 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
108010046516 Wheat Germ Agglutinins Proteins 0.000 description 1
206010048038 Wound infection Diseases 0.000 description 1
241001494424 [Eubacterium] brachy Species 0.000 description 1
206010000059 abdominal discomfort Diseases 0.000 description 1
206010060926 abdominal symptom Diseases 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000008649 adaptation response Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000000910 agglutinin Substances 0.000 description 1
101150113943 algD gene Proteins 0.000 description 1
HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
102000005840 alpha-Galactosidase Human genes 0.000 description 1
108010030291 alpha-Galactosidase Proteins 0.000 description 1
102000016679 alpha-Glucosidases Human genes 0.000 description 1
108010074504 alpha-phosphotrehalase alpha Proteins 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000003862 amino acid derivatives Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
MXZRMHIULZDAKC-UHFFFAOYSA-L ammonium magnesium phosphate Chemical compound [NH4+].[Mg+2].[O-]P([O-])([O-])=O MXZRMHIULZDAKC-UHFFFAOYSA-L 0.000 description 1
CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
238000002669 amniocentesis Methods 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
238000002583 angiography Methods 0.000 description 1
238000002399 angioplasty Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000007953 anoxia Effects 0.000 description 1
PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
150000004056 anthraquinones Chemical class 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
GOOXRYWLNNXLFL-UHFFFAOYSA-H azane oxygen(2-) ruthenium(3+) ruthenium(4+) hexachloride Chemical compound N.N.N.N.N.N.N.N.N.N.N.N.N.N.[O--].[O--].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3].[Ru+3].[Ru+4] GOOXRYWLNNXLFL-UHFFFAOYSA-H 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
IUHDTQIYNQQIBP-UHFFFAOYSA-M benzyl-ethyl-dimethylazanium;chloride Chemical compound [Cl-].CC[N+](C)(C)CC1=CC=CC=C1 IUHDTQIYNQQIBP-UHFFFAOYSA-M 0.000 description 1
108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
108010047754 beta-Glucosidase Proteins 0.000 description 1
102000006995 beta-Glucosidase Human genes 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000007698 birth defect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
208000037815 bloodstream infection Diseases 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
230000009172 bursting Effects 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
150000001728 carbonyl compounds Chemical class 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000009087 cell motility Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
229940106157 cellulase Drugs 0.000 description 1
235000019398 chlorine dioxide Nutrition 0.000 description 1
RPKLZQLYODPWTM-KBMWBBLPSA-N cholanoic acid Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC(O)=O)C)[C@@]1(C)CC2 RPKLZQLYODPWTM-KBMWBBLPSA-N 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
208000034391 chronic adult periodontitis Diseases 0.000 description 1
208000001277 chronic periodontitis Diseases 0.000 description 1
208000013507 chronic prostatitis Diseases 0.000 description 1
229960005233 cineole Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
229960003346 colistin Drugs 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000005094 computer simulation Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
238000011217 control strategy Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
210000004087 cornea Anatomy 0.000 description 1
239000006184 cosolvent Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000012864 cross contamination Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000010779 crude oil Substances 0.000 description 1
235000019316 curdlan Nutrition 0.000 description 1
229940078035 curdlan Drugs 0.000 description 1
108010005400 cutinase Proteins 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
YSYKRGRSMLTJNL-URARBOGNSA-N dTDP-alpha-D-glucose Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)C1 YSYKRGRSMLTJNL-URARBOGNSA-N 0.000 description 1
238000001804 debridement Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000003479 dental cement Substances 0.000 description 1
210000003298 dental enamel Anatomy 0.000 description 1
239000004053 dental implant Substances 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
ATKXDQOHNICLQW-UHFFFAOYSA-N dichloralphenazone Chemical compound OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl.CN1C(C)=CC(=O)N1C1=CC=CC=C1 ATKXDQOHNICLQW-UHFFFAOYSA-N 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
210000003027 ear inner Anatomy 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
229940092559 enterobacter aerogenes Drugs 0.000 description 1
229940032049 enterococcus faecalis Drugs 0.000 description 1
210000001842 enterocyte Anatomy 0.000 description 1
230000000369 enteropathogenic effect Effects 0.000 description 1
238000010799 enzyme reaction rate Methods 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
210000002388 eustachian tube Anatomy 0.000 description 1
238000004299 exfoliation Methods 0.000 description 1
210000003499 exocrine gland Anatomy 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
230000005294 ferromagnetic effect Effects 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
229920002457 flexible plastic Polymers 0.000 description 1
229920002313 fluoropolymer Polymers 0.000 description 1
229940124307 fluoroquinolone Drugs 0.000 description 1
235000003086 food stabiliser Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
235000013611 frozen food Nutrition 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
239000000295 fuel oil Substances 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
235000006171 gluten free diet Nutrition 0.000 description 1
235000020884 gluten-free diet Nutrition 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
108091005608 glycosylated proteins Proteins 0.000 description 1
102000035122 glycosylated proteins Human genes 0.000 description 1
210000002175 goblet cell Anatomy 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000010370 hearing loss Effects 0.000 description 1
231100000888 hearing loss Toxicity 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
230000008543 heat sensitivity Effects 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
230000009215 host defense mechanism Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
239000003906 humectant Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000008676 import Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
239000003262 industrial enzyme Substances 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
210000002490 intestinal epithelial cell Anatomy 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
239000001573 invertase Substances 0.000 description 1
235000011073 invertase Nutrition 0.000 description 1
238000002955 isolation Methods 0.000 description 1
DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
239000002523 lectin Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000003446 ligand Substances 0.000 description 1
229960003907 linezolid Drugs 0.000 description 1
TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 description 1
239000003120 macrolide antibiotic agent Substances 0.000 description 1
229940041033 macrolides Drugs 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
230000005389 magnetism Effects 0.000 description 1
201000007261 marantic endocarditis Diseases 0.000 description 1
210000001006 meconium Anatomy 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000037353 metabolic pathway Effects 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
150000001455 metallic ions Chemical class 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229960001047 methyl salicylate Drugs 0.000 description 1
230000003641 microbiacidal effect Effects 0.000 description 1
230000003158 microbiostatic effect Effects 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
230000000420 mucociliary effect Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
210000003928 nasal cavity Anatomy 0.000 description 1
239000005445 natural material Substances 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
208000016135 nonbacterial thrombotic endocarditis Diseases 0.000 description 1
230000009972 noncorrosive effect Effects 0.000 description 1
RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 1
239000000820 nonprescription drug Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229960000988 nystatin Drugs 0.000 description 1
VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
230000000414 obstructive effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000011368 organic material Substances 0.000 description 1
208000005923 otitis media with effusion Diseases 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000002351 pectolytic effect Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
210000002379 periodontal ligament Anatomy 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
108091000115 phosphomannomutase Proteins 0.000 description 1
229950004354 phosphorylcholine Drugs 0.000 description 1
229940085127 phytase Drugs 0.000 description 1
239000006187 pill Substances 0.000 description 1
238000009372 pisciculture Methods 0.000 description 1
230000008121 plant development Effects 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
208000030761 polycystic kidney disease Diseases 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
239000003910 polypeptide antibiotic agent Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000036515 potency Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
239000000955 prescription drug Substances 0.000 description 1
238000004321 preservation Methods 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
150000003138 primary alcohols Chemical class 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000010069 protein adhesion Effects 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
239000000007 protein synthesis inhibitor Substances 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
229940007042 proteus vulgaris Drugs 0.000 description 1
WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 description 1
229960005442 quinupristin Drugs 0.000 description 1
108700028429 quinupristin Proteins 0.000 description 1
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
235000021067 refined food Nutrition 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
229960002181 saccharomyces boulardii Drugs 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
150000003333 secondary alcohols Chemical class 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910001923 silver oxide Inorganic materials 0.000 description 1
235000021309 simple sugar Nutrition 0.000 description 1
201000009890 sinusitis Diseases 0.000 description 1
244000005714 skin microbiome Species 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
ZFMRLFXUPVQYAU-UHFFFAOYSA-N sodium 5-[[4-[4-[(7-amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]-2-hydroxybenzoic acid Chemical compound C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)N=NC5=CC(=C(C=C5)O)C(=O)O.[Na+] ZFMRLFXUPVQYAU-UHFFFAOYSA-N 0.000 description 1
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical class [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
235000010344 sodium nitrate Nutrition 0.000 description 1
229960004025 sodium salicylate Drugs 0.000 description 1
YHRRZDLNOVFJKG-UHFFFAOYSA-M sodium;n-bromosulfamate Chemical compound [Na+].[O-]S(=O)(=O)NBr YHRRZDLNOVFJKG-UHFFFAOYSA-M 0.000 description 1
FZMJSKDUGCSOLI-UHFFFAOYSA-M sodium;n-chlorosulfamate Chemical compound [Na+].[O-]S(=O)(=O)NCl FZMJSKDUGCSOLI-UHFFFAOYSA-M 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000004287 spin echo double resonance Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
230000019086 sulfide ion homeostasis Effects 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000001732 thrombotic effect Effects 0.000 description 1
229960000790 thymol Drugs 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
102000003601 transglutaminase Human genes 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000014616 translation Effects 0.000 description 1
238000004627 transmission electron microscopy Methods 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
125000000647 trehalose group Chemical group 0.000 description 1
108010045348 trehalose synthase Proteins 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
210000003812 trophozoite Anatomy 0.000 description 1
210000001944 turbinate Anatomy 0.000 description 1
238000007039 two-step reaction Methods 0.000 description 1
238000010246 ultrastructural analysis Methods 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
230000002861 ventricular Effects 0.000 description 1
230000035899 viability Effects 0.000 description 1
238000002460 vibrational spectroscopy Methods 0.000 description 1
229940118696 vibrio cholerae Drugs 0.000 description 1
239000000304 virulence factor Substances 0.000 description 1
230000007923 virulence factor Effects 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
239000003643 water by type Substances 0.000 description 1
239000002569 water oil cream Substances 0.000 description 1
239000003021 water soluble solvent Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1